Quarterly report pursuant to Section 13 or 15(d)

Accounts Receivable - Schedule of Accounts Receivable (Details)

v3.19.3.a.u2
Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Accounts receivable, gross $ 45,793,510 $ 32,229,653
Less: Amount purchased by factors (1,572,000)
Less: Allowance for discounts
Less: Allowance for bad debts (2,787,894) (2,777,521)
Accounts receivable, net 5,108,462 3,811,749
Clinical Laboratory Operations [Member]    
Accounts receivable, gross 41,750 622,009
Less: Allowance for discounts (26,182) (573,584)
Hospitals Operations [Member]    
Accounts receivable, gross 45,804,056 31,607,644
Less: Allowance for discounts (36,298,972) (25,066,799)
Other [Member]    
Accounts receivable, gross $ (52,296)